Market Closed -
Other stock markets
|
After market 03:51:46 pm | |||
3.637 EUR | +1.28% | 3.63 | -0.19% |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Mar. 26 | Valneva: Phase 1 trial initiated in the Zika virus | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.94% | 539M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |
- Stock
- Equities
- Stock Valneva - Euronext Paris
- News Valneva
- Valneva's COVID-19 Booster Improves Immunity in Early-Stage Study